title: Bioequivalence study of ondansetron tablet in healthy Thai male volunteers.
abstract: OBJECTIVE
  To assess the average bioequivalence of two formulations of 8-mg ondansetron tablets--test product (Unison Laboratories, Thailand) and reference product (Glaxo Wellcome, USA)--in 14 healthy Thai male volunteers.
  
  
  METHODS
  In a randomized, single dose, fasting, two-period, crossover study design with a 1-week washout period, each subject received an 8-mg ondansetron tablet. Serum samples were collected over a 24-hour period after administration. Subsequently serum concentrations of ondansetron were analyzed by using a validated HPLC-UV method. Pharmacokinetic parameters were determined by using non-compartmental analysis.
  
  
  RESULTS
  No significant difference was observed in any of the pharmacokinetic parameters analyzed. The time to reach the maximal concentration (Tmax, hour), the peak concentration (Cmax, ng/ ml) and the area under the concentration-time curve (AUC(0-infinity), ng x h/ml) of ondansetron for reference and test preparations were 2.6 + 1.8 vs 2.2 + 0.6, 49.5 +/- 18.9 vs 48.5 +/- 13.7 and 352.2 +/- 184.7 vs 323.8 +/- 154.5, respectively. The 90 per cent confidence intervals for Test/Reference ratio of Cmax and AUC(0-infinity) were found within the bioequivalence range of 80-125 per cent (90.3-110.0% and 88.4-99.6%, respectively).
  
  
  CONCLUSIONS
  The bioequivalence of these two ondansetron preparations was demonstrated.
authors.affiliation: Bioequivalence Test Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
authors.forename: Manupat
authors.initials: M
authors.lastname: Lohitnavy
authors.forename: Kasinee
authors.initials: K
authors.lastname: Chaijittiprasert
authors.forename: Sanglar
authors.initials: S
authors.lastname: Polnok
authors.forename: Ornrat
authors.initials: O
authors.lastname: Lohitnavy
authors.forename: Prawit
authors.initials: P
authors.lastname: Taytiwat
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000932:Antiemetics / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017294:Ondansetron / Q000008:administration & dosage / Q000493:pharmacokinetics*; D012016:Reference Values; D013607:Tablets; D013785:Thailand; D013810:Therapeutic Equivalency
chemical_list: D000932:Antiemetics; D013607:Tablets; D017294:Ondansetron